The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway

Biochemical and Biophysical Research Communications

Volumn 319, Issue 1, 2004, Pages 275-282

  Imoto, Seiyu ^a   Sugiyama, Kenji ^a   Yamamoto, Tetsuya ^a   Matsuda, Tadashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

BMP; PIASy; RING domain; Smad; Transcription

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; PROTEIN INHIBITOR; PROTEIN PIASY; SMAD PROTEIN; STAT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BLOTTING, NORTHERN; BONE MORPHOGENETIC PROTEINS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 2442686416     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.161     Document Type: Article

References (48)

1. Reddi A.H. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev. 8:1997;11-20
2. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10:1996;1580-1594
3. Kawabata M., Imamura T., Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 9:1998;49-61
4. Massagué J. TGF-β signal transduction. Annu. Rev. Biochem. 67:1998;753-791
5. Heldin C.H., Miyazono K., ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471
6. Derynck R., Zhang Y., Feng X.H. Smads: transcriptional activators of TGF-β responses. Cell. 95:1998;737-740
7. Autzen P., Robson C.N., Bjartell A., Malcolm A.J., Johnson M.I., Neal D.E., Hamdy F.C. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br. J. Cancer. 78:1998;1219-1223
8. Kim I.Y., Lee D.H., Ahn H.J., Tokunaga H., Song W., Devereaux L.M., Jin D., Sampath T.K., Morton R.A. Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. Cancer Res. 60:2000;2840-2844
9. Heikinheimo K.A., Laine M.A., Ritvos O.V., Voutilainen R.J., Hogan B.L., Leivo I.V., Heikinheimo A.K. Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland. Cancer Res. 59:1999;5815-5821
10. Howe J.R., Bair J.L., Sayed M.G., Anderson M.E., Mitros F.A., Petersen G.M., Velculescu V.E., Traverso G., Vogelstein B. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28:2001;184-187
11. Shepherd T.G., Nachtigal M.W. Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology. 144:2003;3306-3314
12. Balemans W., Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. 250:2002;231-250
13. Hollnagel A., Oehlmann V., Heymer J., Ruther U., Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274:1999;19838-19845
14. Clement J.H., Marr N., Meissner A., Schwalbe M., Sebald W., Kliche K.O., Hoffken K., Wolfl S. Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. J. Cancer Res. Clin. Oncol. 126:2000;271-279
15. Korchynskyi, ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277:2002;4883-4891
16. Imoto S., Sugiyama K., Muromoto R., Sato N., Yamamoto T., Matsuda T. Regulation of TGF-β signaling by protein inhibitor of activated STAT, PIASy through Smad3. J. Biol. Chem. 278:2003;34253-34258
17. Shuai K. Modulation of STAT signaling by STAT-interacting proteins. Oncogene. 19:2000;2638-2644
18. Liu B., Liao J., Rao X., Kushner S.A., Chung C.D., Chang D.D., Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA. 95:1998;10626-10631
19. Chung C.D., Liao J., Liu B., Rao X., Jay P., Berta P., Shuai K. Specific inhibition of Stat3 signal transduction by PIAS3. Science. 278:1997;1803-1805
20. Kotaja N., Aittomaki S., Silvennoinen O., Palvimo J.J., Janne O.A. ARIP3 androgen receptor-interacting protein 3 and other PIAS protein inhibitor of activated STAT proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol. Endocrinol. 14:2000;1986-2000
21. Junicho A., Matsuda T., Yamamoto T., Kishi H., Korkmaz K., Saatcioglu F., Fuse H., Muraguchi A. Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells. Biochem. Biophys. Res. Commun. 278:2000;9-13
22. Gross M., Liu B., Tan J., French F.S., Carey M., Shuai K. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene. 20:2001;3880-3887
23. Jackson P.K. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15:2001;3053-3058
24. Kahyo T., Nishida T., Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell. 8:2001;713-718
25. Nelson V., Davis G.E., Maxwell S.A. A putative protein inhibitor of activated STAT PIASy interacts with p53 and inhibits p53-mediated transactivation but not apoptosis. Apoptosis. 6:2001;221-234
26. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F., Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15:2001;3088-3103
27. Yamamoto H., Ihara M., Matsuura Y., Kikuchi A. Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. EMBO J. 22:2003;2047-2059
28. Long J., Matsuura I., He D., Wang G., Shuai K., Liu F. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. Proc. Natl. Acad. Sci. USA. 100:2003;9791-9796
29. Kawabata M., Inoue H., Hanyu A., Imamura T., Miyazono K. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17:1998;4056-4065
30. Kusanagi K., Inoue H., Ishidou Y., Mishima H.K., Kawabata M., Miyazono K. Characterization of a bone morphogenetic protein-responsive Smad-binding element. Mol. Biol. Cell. 11:2000;555-565
31. Carcamo J., Zentella A., Massagué J. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol. Cell. Biol. 15:1995;1573-1581
32. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M., Ariga H. DJ-1 Positively regulates the androgen receptor by impairing the binding of PIASxα to the receptor. J. Biol. Chem. 276:2001;37556-37563
33. Matsuda T., Yamamoto T., Kishi H., Yoshimura A., Muraguchi A. SOCS-1 can suppress CD3ζ- and Syk-mediated NF-AT activation in a non-lymphoid cell line. FEBS Lett. 47:2000;235-240
34. Yamamoto T., Matsuda T., Muraguchi A., Miyazono K., Kawabata K. Cross-talk between IL-6 and TGF-β signaling in hepatoma cells. FEBS Lett. 492:2001;247-253
35. Cammenga J., Mulloy J.C., Berguido F.J., MacGrogan D., Viale A., Nimer S.D. Induction of C/EBPα activity alters gene expression and differentiation of human CD34+ cells. Blood. 101:2003;2206-2214
36. Wang L.H., Yang X.Y., Mihalic K., Xiao W., Li D., Farrar W.L. Activation of Estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3. J. Biol. Chem. 276:2001;31839-31844
37. Desprez P.Y., Lin C.Q., Thomasset N., Sympson C.J., Bissell M.J., Campisi J. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol. Cell. Biol. 18:1998;4577-4588
38. Norton J.D., Atherton G.T. Coupling of cell growth control and apoptosis functions of Id proteins. Mol. Cell. Biol. 18:1998;2371-2381
39. Wice B.M., Gordon J.I. Forced expression of Id-1 in the adult mouse small intestinal epithelium is associated with development of adenomas. J. Biol. Chem. 273:1998;25310-25319
40. Kleeff J., Ishiwata T., Friess H., Buchler M.W., Israel M.A., Korc M. The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer. Cancer Res. 58:1998;3769-3772
41. Yamamoto T., Saatcioglu F., Matsuda T. Cross-talk between bone morphogenetic proteins and estrogen receptor signaling. Endocrinology. 143:2002;2635-2642
42. Hay R.T. Protein modification by SUMO. Trends Biochem. Sci. 26:2001;332-333
43. Miyazono K., Kusanagi K., Inoue H. Divergence and convergence of TGF-β/BMP signaling. J. Cell Physiol. 187:2001;265-276
44. Zwijsen A., Verschueren K., Huylebroeck D. New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Lett. 546:2003;133-139
45. Zhu H., Kavsak P., Abdollah S., Wrana J.L., Thomsen G.H. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature. 400:1999;687-693
46. Lin X., Liang M., Feng X.H. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor- signaling. J. Biol. Chem. 275:2000;36818-36822
47. Ebisawa T., Fukuchi M., Murakami G., Chiba T., Tanaka K., Imamura T., Miyazono K. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276:2001;12477-12480
48. Kavsak P., Rasmussen R.K., Causing C.G., Bonni S., Zhu H., Thomsen G.H., Wrana J.L. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-β receptor for degradation. Mol. Cell. 6:2000;1365-1375